Literature DB >> 9853830

Angiogenesis and apoptosis are cellular parameters of neoplastic progression in transgenic mouse models of tumorigenesis.

G Bergers1, D Hanahan, L M Coussens.   

Abstract

The epidemiology and histopathology of human cancers and studies of animal models of tumorigenesis have led to a widely-accepted notion that multiple genetic and epigenetic changes have to accrue for the successful development of a malignant phenotype. Tumor growth and expansion requires an ability not only to proliferate, but also to down-modulate cell death (apoptosis) and activate angiogenesis to produce a tumor neovasculature. This review will describe the interplay between apoptosis and proliferation, as well as the characteristics of the angiogenic phenotype in two transgenic mouse models of multi-step tumorigenesis, namely, pancreatic islet cell carcinomas and squamous cell carcinomas of the skin.

Entities:  

Mesh:

Year:  1998        PMID: 9853830

Source DB:  PubMed          Journal:  Int J Dev Biol        ISSN: 0214-6282            Impact factor:   2.203


  23 in total

Review 1.  Intravital fluorescence videomicroscopy to study tumor angiogenesis and microcirculation.

Authors:  P Vajkoczy; A Ullrich; M D Menger
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

2.  Building a better Trap.

Authors:  John D Hood; David A Cheresh
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-14       Impact factor: 11.205

3.  Inhibitory effect of antisense vascular endothelial growth factor 165 eukaryotic expression vector on proliferation of hepatocellular carcinoma cells.

Authors:  Song Gu; Chang-Jian Liu; Tong Qiao; Xue-Mei Sun; Lei-Lei Chen; Le Zhang
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

4.  PDGFRbeta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival.

Authors:  Steven Song; Andrew J Ewald; William Stallcup; Zena Werb; Gabriele Bergers
Journal:  Nat Cell Biol       Date:  2005-08-21       Impact factor: 28.824

Review 5.  Matrix metalloproteinases and the regulation of tissue remodelling.

Authors:  Andrea Page-McCaw; Andrew J Ewald; Zena Werb
Journal:  Nat Rev Mol Cell Biol       Date:  2007-03       Impact factor: 94.444

Review 6.  Molecular mechanisms of tumor angiogenesis and tumor progression.

Authors:  U Cavallaro; G Christofori
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

7.  Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis.

Authors:  L M Coussens; W W Raymond; G Bergers; M Laig-Webster; O Behrendtsen; Z Werb; G H Caughey; D Hanahan
Journal:  Genes Dev       Date:  1999-06-01       Impact factor: 11.361

Review 8.  Role of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases in skin cancer.

Authors:  Chuan-Ming Xie; Wenyi Wei; Yi Sun
Journal:  J Genet Genomics       Date:  2013-02-10       Impact factor: 4.275

9.  Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors.

Authors:  Gabriele Bergers; Steven Song; Nicole Meyer-Morse; Emily Bergsland; Douglas Hanahan
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

10.  Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens: disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/Connective tissue growth factor angiogenic inhibitory complexes by MMP-2 proteolysis.

Authors:  Richard A Dean; Georgina S Butler; Yamina Hamma-Kourbali; Jean Delbé; David R Brigstock; José Courty; Christopher M Overall
Journal:  Mol Cell Biol       Date:  2007-10-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.